Latest papers

Mutations in the ectodomain of newcastle disease virus fusion protein confer a hemagglutinin-neuraminidase-independent phenotype.

Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice.

Interactions and oligomerization of hantavirus glycoproteins.

[Molecular genetic characteristics of the newcastle disease virus velogenic strains isolated in Russia, Ukraine, Kazakhstan, and Kirghizia].

Novel therapies for an old virus: treatment of RSV infections in the 21st Century

Secondary RNA structure and its role in RNA interference to silence the respiratory syncytial virus fusion protein gene.

Surveillance for avirulent Newcastle disease viruses in domestic ducks (Anas platyrhynchos and Cairina moschata) at live bird markets in Eastern China and characterization of the viruses isolated.

[Expression and purification of a secreted form of fusion glycoprotein of human respiratory syncytial virus encoded by recombinant baculovirus].

GI-5005, a yeast vector vaccine expressing an NS3-core fusion protein for chronic HCV infection.

Effect of interleukin-15 on the course of myocarditis in Coxsackievirus B3-infected BALB/c mice.

Genotypic and phylogenetic analysis of the G gene of respiratory syncytial virus isolates in Okinawa, Japan, 2008.

Identification of novel target sites and an inhibitor of the dengue virus E protein.

[The genetic characteristic analysis of fusion gene measles wild viruses of China in 2006].

Development of antibody fragments for immunotherapy of prion diseases

Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice

[High level expression of 5-helix protein in HIV gp41 heptad repeat regions and its virus fusion-inhibiting activity].

Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus.

[Effects of disulfide bridges in glycoprotein E1 on the membrane fusion activity of rubella virus].

Genetically engineered Newcastle disease virus for malignant melanoma therapy

[Biological characteristics and sequence analysis of fusion genes of Newcastle disease virus isolates].